Elevated Plasma Lipoprotein(a) Is Associated With Coronary Artery Disease in Patients With Chronic Stable Angina Pectoris 11Dr. Cox is supported by a Fellowship Grant from the British Heart Foundation, London.

This publication has 38 references indexed in Scilit:

• Risk of Primary and Recurrent Acute Myocardial Infarction From Lipoprotein(a) in Men and Women11This study was supported by grants from the National Heart Foundation of Australia, National Health and Medical Research Council of Australia, Newcastle.
  Journal of the American College of Cardiology, 1996
• Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS)
  European Journal of Clinical Investigation, 1994
• Effects of lipoprotein(a) on the binding of plasminogen to fibrin and its activation by fibrin-bound tissue-type plasminogen activator
  Chemistry and Physics of Lipids, 1994
• Lipoprotein(a) binds to human platelets and attenuates plasminogen binding and activation
  Biochemistry, 1993
• Prevalence of lipoprotein (a) [Lp(a)] excess in coronary artery disease
  The American Journal of Cardiology, 1991
• Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men.
  BMJ, 1990
• The Mysteries Of Lipoprotein(a)
  Science, 1989
• A potential basis for the thrombotic risks associated with lipoprotein(a)
  Nature, 1989
• cDNA sequence of human apolipoprotein(a) is homologous to plasminogen
  Nature, 1987
• A NEW SERUM TYPE SYSTEM IN MAN—THE L_p SYSTEM
  Acta Pathologica Microbiologica Scandinavica, 1963